Your browser doesn't support javascript.
loading
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.
Campbell, J R; Chan, E D; Anderson, L F; Bonnet, M; Brode, S K; Cegielski, J P; Guglielmetti, L; Singla, R; Fox, G J; Skrahina, A; Rodrigues, D; Kuksa, L; Viiklepp, P; Menzies, D.
Affiliation
  • Campbell JR; Department of Medicine & Department of Global and Public Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada, McGill International TB Centre, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluat
  • Chan ED; Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, USA, Department of Academic Affairs, National Jewish Health, Denver, CO, USA, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
  • Anderson LF; Strategic Information for Response, Global Malaria Programme, World Health Organization, Geneva, Switzerland.
  • Bonnet M; University of Montpellier, Recherches Translationnelles sur le VIH et les Maladies Infectieuses, Institut de Recherche pour le Developpement, Institut national de la santé et de la recherche médicale (INSERM), Montpellier, France, Epicentre, Paris, France.
  • Brode SK; Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON Canada, Department of Medicine, Division of Respirology, University Health Network, Toronto, ON Canada, Department of Medicine, University of Toronto, Toronto, ON Canada.
  • Cegielski JP; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Guglielmetti L; Sorbonne Université, Centre d´Immunologie et des Maladies Infectieuses (Cimi-Paris), INSERM, U1135, Paris, France, Assistance Publique Hôpitaux de Paris Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Laboratoire de Bactériologie-Hygiène, Hôp
  • Singla R; Department of TB and Respiratory Diseases, National Institute of TB and Respiratory Diseases, New Delhi, India.
  • Fox GJ; University of Sydney, Sydney, NSW, Australia.
  • Skrahina A; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Rodrigues D; Instituto Clemente Ferreira, São Paulo, SP, Brazil.
  • Kuksa L; Department of MDR TB, Riga East University Hospital, Riga, Latvia.
  • Viiklepp P; Department of Registries, National Institute for Health Development, Tallinn, Estonia.
  • Menzies D; McGill International TB Centre, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Department of Epidemiology, Biostatistics, and Occupational Healt
Int J Tuberc Lung Dis ; 27(4): 338-340, 2023 04 01.
Article in En | MEDLINE | ID: mdl-37035974
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Mycobacterium tuberculosis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2023 Document type: Article Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Mycobacterium tuberculosis Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2023 Document type: Article Country of publication: France